| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diarrhea | 12 | 2016 | 316 | 2.750 |
Why?
|
| Inflammatory Bowel Diseases | 10 | 2015 | 314 | 2.420 |
Why?
|
| Colon | 27 | 2010 | 353 | 2.000 |
Why?
|
| Gastrointestinal Diseases | 6 | 2016 | 333 | 1.210 |
Why?
|
| Sodium | 16 | 2001 | 294 | 1.080 |
Why?
|
| Gastrointestinal Hemorrhage | 6 | 2018 | 223 | 0.950 |
Why?
|
| Intestine, Small | 4 | 2014 | 313 | 0.900 |
Why?
|
| Intestinal Absorption | 14 | 2016 | 190 | 0.820 |
Why?
|
| Crohn Disease | 6 | 2014 | 283 | 0.790 |
Why?
|
| Disabled Persons | 2 | 2014 | 101 | 0.720 |
Why?
|
| Breath Tests | 4 | 2015 | 179 | 0.680 |
Why?
|
| beta Catenin | 6 | 2008 | 206 | 0.680 |
Why?
|
| Disability Evaluation | 2 | 2012 | 193 | 0.680 |
Why?
|
| Diabetes Complications | 3 | 2009 | 196 | 0.620 |
Why?
|
| Intestinal Mucosa | 14 | 2016 | 776 | 0.620 |
Why?
|
| Capsule Endoscopy | 1 | 2018 | 20 | 0.600 |
Why?
|
| Serologic Tests | 3 | 2014 | 118 | 0.560 |
Why?
|
| Cecum | 6 | 1994 | 27 | 0.500 |
Why?
|
| Feces | 4 | 2016 | 715 | 0.480 |
Why?
|
| Leukocyte L1 Antigen Complex | 2 | 2016 | 15 | 0.470 |
Why?
|
| Alopecia | 1 | 2015 | 37 | 0.470 |
Why?
|
| Mexican Americans | 2 | 2006 | 204 | 0.460 |
Why?
|
| Bile Acids and Salts | 4 | 2014 | 244 | 0.440 |
Why?
|
| Hyperplasia | 7 | 2008 | 209 | 0.430 |
Why?
|
| Diet Therapy | 1 | 2013 | 41 | 0.420 |
Why?
|
| Antibodies, Fungal | 3 | 2012 | 13 | 0.420 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 3 | 2012 | 35 | 0.410 |
Why?
|
| Amyloidosis | 1 | 2013 | 67 | 0.410 |
Why?
|
| Intestinal Diseases | 1 | 2013 | 84 | 0.410 |
Why?
|
| Disease Management | 1 | 2016 | 519 | 0.400 |
Why?
|
| Chronic Disease | 7 | 2016 | 1182 | 0.400 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2015 | 243 | 0.400 |
Why?
|
| Rabbits | 19 | 1998 | 711 | 0.400 |
Why?
|
| Colitis, Ulcerative | 3 | 2014 | 208 | 0.400 |
Why?
|
| Colonic Neoplasms | 3 | 2004 | 247 | 0.360 |
Why?
|
| Amiloride | 12 | 1998 | 29 | 0.360 |
Why?
|
| Fatty Acids, Volatile | 5 | 2001 | 33 | 0.350 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2008 | 64 | 0.340 |
Why?
|
| Cell Division | 6 | 2005 | 781 | 0.340 |
Why?
|
| Precancerous Conditions | 2 | 2004 | 283 | 0.340 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2014 | 256 | 0.330 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2012 | 426 | 0.330 |
Why?
|
| Antidiarrheals | 1 | 2009 | 17 | 0.330 |
Why?
|
| Glutens | 1 | 2009 | 10 | 0.320 |
Why?
|
| Humans | 51 | 2018 | 124332 | 0.320 |
Why?
|
| Malabsorption Syndromes | 2 | 2009 | 36 | 0.310 |
Why?
|
| Ileum | 6 | 1990 | 132 | 0.310 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2008 | 9 | 0.310 |
Why?
|
| Calcium, Dietary | 2 | 2010 | 37 | 0.310 |
Why?
|
| Cytoskeletal Proteins | 4 | 2005 | 268 | 0.300 |
Why?
|
| Epithelial Cells | 4 | 2008 | 911 | 0.300 |
Why?
|
| Stomach Ulcer | 1 | 2008 | 92 | 0.300 |
Why?
|
| Mass Screening | 1 | 2013 | 784 | 0.290 |
Why?
|
| Diet | 3 | 2013 | 1131 | 0.290 |
Why?
|
| Gastric Bypass | 1 | 2008 | 70 | 0.280 |
Why?
|
| Protein Kinase C | 5 | 2006 | 150 | 0.270 |
Why?
|
| Bacterial Infections | 1 | 2009 | 306 | 0.260 |
Why?
|
| Genes, APC | 1 | 2005 | 13 | 0.250 |
Why?
|
| Chlorides | 9 | 2000 | 106 | 0.250 |
Why?
|
| Trans-Activators | 4 | 2005 | 807 | 0.250 |
Why?
|
| Cell Nucleus | 5 | 2008 | 677 | 0.250 |
Why?
|
| Bicarbonates | 7 | 1998 | 98 | 0.240 |
Why?
|
| Membrane Potentials | 8 | 2006 | 304 | 0.240 |
Why?
|
| Pectins | 2 | 2003 | 4 | 0.240 |
Why?
|
| Hydrogen-Ion Concentration | 9 | 1998 | 426 | 0.240 |
Why?
|
| Propionates | 3 | 1994 | 30 | 0.230 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2004 | 28 | 0.230 |
Why?
|
| Attitude to Health | 1 | 2006 | 261 | 0.230 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 2003 | 8 | 0.220 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2015 | 281 | 0.220 |
Why?
|
| Epinephrine | 10 | 1998 | 177 | 0.220 |
Why?
|
| Stem Cells | 1 | 2008 | 701 | 0.220 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 185 | 0.220 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 224 | 0.220 |
Why?
|
| Constipation | 2 | 2008 | 113 | 0.210 |
Why?
|
| Male | 35 | 2018 | 60988 | 0.210 |
Why?
|
| Cyclic AMP | 5 | 2006 | 248 | 0.210 |
Why?
|
| Databases, Factual | 1 | 2007 | 1174 | 0.200 |
Why?
|
| Immunoprecipitation | 3 | 2008 | 199 | 0.200 |
Why?
|
| Patient Selection | 2 | 2005 | 688 | 0.200 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 215 | 0.200 |
Why?
|
| Glycoproteins | 1 | 2004 | 369 | 0.200 |
Why?
|
| Fluid Therapy | 2 | 1999 | 126 | 0.190 |
Why?
|
| Animals | 31 | 2010 | 34134 | 0.190 |
Why?
|
| Escherichia coli Proteins | 1 | 2003 | 305 | 0.180 |
Why?
|
| Diagnosis, Differential | 4 | 2012 | 1887 | 0.180 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2014 | 83 | 0.180 |
Why?
|
| Liver | 1 | 2008 | 1760 | 0.180 |
Why?
|
| Adult | 16 | 2018 | 29378 | 0.170 |
Why?
|
| Vibrio cholerae | 1 | 1999 | 26 | 0.170 |
Why?
|
| Cholera Toxin | 1 | 1999 | 45 | 0.170 |
Why?
|
| Cholera | 1 | 1999 | 25 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 1241 | 0.160 |
Why?
|
| Female | 21 | 2018 | 66265 | 0.160 |
Why?
|
| Postoperative Complications | 3 | 2014 | 3062 | 0.160 |
Why?
|
| Colonic Diseases | 2 | 2010 | 38 | 0.160 |
Why?
|
| Defecation | 1 | 1999 | 29 | 0.160 |
Why?
|
| Drinking | 1 | 1999 | 34 | 0.160 |
Why?
|
| Zinc | 1 | 1999 | 127 | 0.160 |
Why?
|
| Cell Membrane | 4 | 2000 | 460 | 0.160 |
Why?
|
| Organ Transplantation | 1 | 2001 | 164 | 0.150 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2006 | 43 | 0.150 |
Why?
|
| Citrobacter rodentium | 3 | 2010 | 9 | 0.150 |
Why?
|
| TCF Transcription Factors | 2 | 2008 | 17 | 0.150 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2008 | 58 | 0.140 |
Why?
|
| Enterobacteriaceae Infections | 4 | 2010 | 55 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2008 | 1684 | 0.140 |
Why?
|
| In Vitro Techniques | 7 | 1996 | 969 | 0.140 |
Why?
|
| Prognosis | 3 | 2018 | 4554 | 0.140 |
Why?
|
| Intestinal Secretions | 1 | 2016 | 4 | 0.140 |
Why?
|
| Biomarkers, Tumor | 1 | 2004 | 1460 | 0.140 |
Why?
|
| Hemoglobins | 1 | 2018 | 306 | 0.140 |
Why?
|
| Colitis | 2 | 2009 | 154 | 0.130 |
Why?
|
| Cyclin D1 | 2 | 2008 | 112 | 0.130 |
Why?
|
| Middle Aged | 11 | 2018 | 26442 | 0.130 |
Why?
|
| Sodium Channels | 3 | 1994 | 109 | 0.130 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2018 | 133 | 0.130 |
Why?
|
| Fatty Acids | 1 | 1998 | 351 | 0.130 |
Why?
|
| Electric Conductivity | 6 | 1994 | 89 | 0.130 |
Why?
|
| Ion Transport | 4 | 1998 | 52 | 0.120 |
Why?
|
| Mesalamine | 1 | 2015 | 6 | 0.120 |
Why?
|
| Medically Uninsured | 1 | 2015 | 73 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 133 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2007 | 1687 | 0.120 |
Why?
|
| Recurrence | 2 | 2018 | 1423 | 0.120 |
Why?
|
| Protective Factors | 1 | 2015 | 84 | 0.120 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2015 | 79 | 0.120 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 144 | 0.120 |
Why?
|
| Acid-Base Equilibrium | 2 | 1994 | 59 | 0.110 |
Why?
|
| Incidence | 3 | 2009 | 3086 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 60 | 0.110 |
Why?
|
| Potassium | 6 | 1993 | 279 | 0.110 |
Why?
|
| Cations, Divalent | 1 | 1994 | 19 | 0.110 |
Why?
|
| Pancreatic Function Tests | 1 | 2014 | 3 | 0.110 |
Why?
|
| Steatorrhea | 1 | 2014 | 2 | 0.110 |
Why?
|
| Sodium-Hydrogen Exchangers | 3 | 2001 | 40 | 0.110 |
Why?
|
| Omeprazole | 1 | 1994 | 98 | 0.110 |
Why?
|
| Mice | 9 | 2010 | 17722 | 0.110 |
Why?
|
| Tertiary Care Centers | 1 | 2015 | 236 | 0.110 |
Why?
|
| Texas | 2 | 2015 | 3590 | 0.110 |
Why?
|
| Phosphorylation | 2 | 2008 | 1625 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2016 | 186 | 0.110 |
Why?
|
| Biological Transport | 5 | 1993 | 346 | 0.110 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1993 | 52 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 582 | 0.110 |
Why?
|
| China | 1 | 2014 | 245 | 0.110 |
Why?
|
| Peptide Hormones | 1 | 2014 | 68 | 0.110 |
Why?
|
| Biological Products | 1 | 2015 | 118 | 0.100 |
Why?
|
| Mentors | 1 | 2014 | 143 | 0.100 |
Why?
|
| Parenteral Nutrition Solutions | 1 | 2012 | 5 | 0.100 |
Why?
|
| Aged | 6 | 2018 | 19460 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2013 | 180 | 0.100 |
Why?
|
| Social Security | 1 | 2012 | 1 | 0.100 |
Why?
|
| Insurance Benefits | 1 | 2012 | 3 | 0.100 |
Why?
|
| Risk Factors | 4 | 2015 | 10139 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2005 | 1108 | 0.100 |
Why?
|
| Anions | 1 | 1992 | 18 | 0.100 |
Why?
|
| Colon, Sigmoid | 1 | 1992 | 13 | 0.100 |
Why?
|
| Intestinal Obstruction | 1 | 2013 | 97 | 0.100 |
Why?
|
| Cadherins | 2 | 2004 | 165 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 671 | 0.100 |
Why?
|
| Gastroenterology | 1 | 2014 | 191 | 0.100 |
Why?
|
| Esophagus | 1 | 1993 | 215 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2018 | 16223 | 0.090 |
Why?
|
| Faculty, Medical | 1 | 2014 | 262 | 0.090 |
Why?
|
| Gastrointestinal Transit | 2 | 2007 | 21 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2015 | 1246 | 0.090 |
Why?
|
| Epithelium | 4 | 1996 | 361 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 2533 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 418 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 1417 | 0.090 |
Why?
|
| Barium | 3 | 2003 | 17 | 0.090 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 3 | 1997 | 4 | 0.090 |
Why?
|
| Methylprednisolone | 2 | 1992 | 90 | 0.090 |
Why?
|
| Enteral Nutrition | 1 | 2012 | 255 | 0.090 |
Why?
|
| Adenomatous Polyposis Coli Protein | 2 | 2008 | 27 | 0.090 |
Why?
|
| TRPV Cation Channels | 1 | 2010 | 34 | 0.090 |
Why?
|
| Barrett Esophagus | 1 | 1994 | 339 | 0.080 |
Why?
|
| Loperamide | 1 | 2009 | 8 | 0.080 |
Why?
|
| Octreotide | 1 | 2009 | 21 | 0.080 |
Why?
|
| Theophylline | 5 | 1992 | 29 | 0.080 |
Why?
|
| Water-Electrolyte Balance | 3 | 2001 | 80 | 0.080 |
Why?
|
| Clonidine | 1 | 2009 | 35 | 0.080 |
Why?
|
| Sweetening Agents | 1 | 2009 | 33 | 0.080 |
Why?
|
| Calcium Channels | 1 | 2010 | 159 | 0.080 |
Why?
|
| Physicians | 1 | 2016 | 579 | 0.080 |
Why?
|
| International Cooperation | 1 | 2010 | 157 | 0.080 |
Why?
|
| Transcription Factor 4 | 1 | 2008 | 10 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 5106 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2018 | 4730 | 0.080 |
Why?
|
| Frozen Sections | 1 | 2008 | 25 | 0.080 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 37 | 0.080 |
Why?
|
| Celiac Disease | 1 | 2009 | 68 | 0.080 |
Why?
|
| Gastrointestinal Motility | 2 | 2016 | 46 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 3425 | 0.080 |
Why?
|
| Acetylation | 1 | 2008 | 175 | 0.070 |
Why?
|
| Protein Stability | 1 | 2008 | 165 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2007 | 2896 | 0.070 |
Why?
|
| Glucose | 2 | 1992 | 885 | 0.070 |
Why?
|
| Cytoskeleton | 2 | 2006 | 178 | 0.070 |
Why?
|
| Metformin | 1 | 2009 | 147 | 0.070 |
Why?
|
| Protein Transport | 1 | 2008 | 368 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 1991 | 1008 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2005 | 459 | 0.070 |
Why?
|
| Sigmoidoscopy | 1 | 2007 | 9 | 0.070 |
Why?
|
| Gastroparesis | 1 | 2008 | 66 | 0.070 |
Why?
|
| Axin Protein | 1 | 2006 | 18 | 0.070 |
Why?
|
| Kinetics | 4 | 2000 | 1321 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 178 | 0.070 |
Why?
|
| Pharmaceutical Preparations | 1 | 2007 | 79 | 0.070 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2006 | 24 | 0.070 |
Why?
|
| Threonine | 1 | 2006 | 59 | 0.070 |
Why?
|
| Proteasome Inhibitors | 1 | 2006 | 61 | 0.070 |
Why?
|
| Boronic Acids | 1 | 2006 | 48 | 0.070 |
Why?
|
| Bortezomib | 1 | 2006 | 73 | 0.070 |
Why?
|
| Dietary Fiber | 2 | 2003 | 74 | 0.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 109 | 0.070 |
Why?
|
| Pyrazines | 1 | 2006 | 73 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2006 | 93 | 0.060 |
Why?
|
| Specimen Handling | 1 | 2007 | 140 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 1154 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 725 | 0.060 |
Why?
|
| Serine | 1 | 2006 | 173 | 0.060 |
Why?
|
| Cell Membrane Permeability | 1 | 1986 | 73 | 0.060 |
Why?
|
| Colonoscopy | 2 | 2007 | 240 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 437 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 2087 | 0.060 |
Why?
|
| Osmolar Concentration | 2 | 2016 | 177 | 0.060 |
Why?
|
| Ion Channels | 3 | 1994 | 193 | 0.060 |
Why?
|
| Demography | 1 | 2006 | 240 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 266 | 0.060 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2004 | 12 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2010 | 2303 | 0.060 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2004 | 20 | 0.060 |
Why?
|
| Intestines | 2 | 2016 | 573 | 0.060 |
Why?
|
| Perception | 1 | 2006 | 221 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2014 | 3371 | 0.060 |
Why?
|
| Jejunum | 2 | 1984 | 128 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 660 | 0.060 |
Why?
|
| Algorithms | 2 | 2009 | 1612 | 0.060 |
Why?
|
| Citrobacter freundii | 2 | 2001 | 3 | 0.060 |
Why?
|
| Age Factors | 2 | 2014 | 2805 | 0.060 |
Why?
|
| Video Recording | 2 | 2003 | 183 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 348 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 1984 | 54 | 0.060 |
Why?
|
| Amphotericin B | 3 | 1992 | 90 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2005 | 302 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 3576 | 0.050 |
Why?
|
| Hydrogen | 2 | 1994 | 41 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2003 | 42 | 0.050 |
Why?
|
| Adhesins, Bacterial | 1 | 2003 | 75 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1459 | 0.050 |
Why?
|
| Prevalence | 1 | 2009 | 2428 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 1099 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 1288 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6467 | 0.050 |
Why?
|
| Electrophysiology | 2 | 1997 | 270 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 1113 | 0.050 |
Why?
|
| Protein Binding | 1 | 2006 | 1747 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2003 | 198 | 0.050 |
Why?
|
| Adolescent | 2 | 2014 | 19353 | 0.050 |
Why?
|
| Ouabain | 3 | 1990 | 27 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2006 | 820 | 0.050 |
Why?
|
| Cholangiography | 1 | 2001 | 14 | 0.050 |
Why?
|
| Gallstones | 1 | 2001 | 19 | 0.050 |
Why?
|
| Radiography | 1 | 2003 | 827 | 0.050 |
Why?
|
| DNA | 1 | 2006 | 1598 | 0.050 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2001 | 43 | 0.050 |
Why?
|
| Taurodeoxycholic Acid | 2 | 1991 | 4 | 0.050 |
Why?
|
| Base Sequence | 1 | 2005 | 3093 | 0.050 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2001 | 80 | 0.040 |
Why?
|
| Time Factors | 2 | 2008 | 6262 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2001 | 291 | 0.040 |
Why?
|
| Rehydration Solutions | 1 | 1999 | 8 | 0.040 |
Why?
|
| Young Adult | 1 | 2014 | 8978 | 0.040 |
Why?
|
| Calcium | 4 | 1994 | 1095 | 0.040 |
Why?
|
| Magnesium | 2 | 1994 | 121 | 0.040 |
Why?
|
| Cyclic GMP | 2 | 1990 | 91 | 0.040 |
Why?
|
| Urination | 1 | 1999 | 22 | 0.040 |
Why?
|
| Isotonic Solutions | 1 | 1999 | 35 | 0.040 |
Why?
|
| Absorption | 2 | 1992 | 52 | 0.040 |
Why?
|
| Phenotype | 1 | 2008 | 4255 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2003 | 1024 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2014 | 12279 | 0.040 |
Why?
|
| Ions | 2 | 1990 | 22 | 0.040 |
Why?
|
| Water | 1 | 1999 | 184 | 0.040 |
Why?
|
| Proctitis | 1 | 1996 | 6 | 0.030 |
Why?
|
| Substance P | 1 | 2016 | 34 | 0.030 |
Why?
|
| Prostaglandins | 1 | 2016 | 48 | 0.030 |
Why?
|
| Chromogranins | 1 | 2016 | 27 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 549 | 0.030 |
Why?
|
| Enema | 1 | 1996 | 37 | 0.030 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1988 | 24 | 0.030 |
Why?
|
| Permeability | 1 | 2016 | 119 | 0.030 |
Why?
|
| Cell Polarity | 1 | 1997 | 124 | 0.030 |
Why?
|
| HT29 Cells | 2 | 2006 | 45 | 0.030 |
Why?
|
| Buffers | 1 | 1996 | 31 | 0.030 |
Why?
|
| Protein Kinase C beta | 2 | 2006 | 21 | 0.030 |
Why?
|
| Lactoferrin | 1 | 2016 | 77 | 0.030 |
Why?
|
| Cell Size | 1 | 1996 | 80 | 0.030 |
Why?
|
| Microtubules | 1 | 1996 | 197 | 0.030 |
Why?
|
| Ion Channel Gating | 2 | 2006 | 123 | 0.030 |
Why?
|
| Serotonin | 1 | 2016 | 232 | 0.030 |
Why?
|
| Biopsy | 2 | 1992 | 1237 | 0.030 |
Why?
|
| Radiation Injuries | 1 | 1996 | 142 | 0.030 |
Why?
|
| Furosemide | 2 | 2000 | 37 | 0.030 |
Why?
|
| Coumaric Acids | 1 | 1994 | 1 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2006 | 623 | 0.030 |
Why?
|
| Diffusion | 1 | 1994 | 59 | 0.030 |
Why?
|
| Carboxylic Acids | 1 | 1994 | 24 | 0.030 |
Why?
|
| Survival Rate | 1 | 1999 | 2020 | 0.030 |
Why?
|
| Microelectrodes | 1 | 1994 | 42 | 0.030 |
Why?
|
| Solutions | 1 | 1994 | 65 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 409 | 0.030 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2016 | 205 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2014 | 269 | 0.030 |
Why?
|
| Ethacrynic Acid | 1 | 1992 | 4 | 0.030 |
Why?
|
| Nystatin | 1 | 1992 | 2 | 0.030 |
Why?
|
| Desoxycorticosterone | 1 | 1992 | 14 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2014 | 384 | 0.030 |
Why?
|
| Cell Movement | 1 | 1996 | 835 | 0.030 |
Why?
|
| Obesity | 1 | 1984 | 2250 | 0.030 |
Why?
|
| Technetium | 1 | 1992 | 12 | 0.030 |
Why?
|
| Child | 2 | 2005 | 24515 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 1993 | 153 | 0.020 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1992 | 3 | 0.020 |
Why?
|
| Carbonates | 1 | 1992 | 5 | 0.020 |
Why?
|
| Conductometry | 1 | 1992 | 2 | 0.020 |
Why?
|
| Chlorine | 1 | 1992 | 14 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1992 | 151 | 0.020 |
Why?
|
| Acetazolamide | 1 | 1992 | 30 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 356 | 0.020 |
Why?
|
| Biological Transport, Active | 2 | 1991 | 87 | 0.020 |
Why?
|
| Duodenal Neoplasms | 1 | 1991 | 21 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1992 | 253 | 0.020 |
Why?
|
| Second Messenger Systems | 1 | 1990 | 12 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1990 | 51 | 0.020 |
Why?
|
| Bumetanide | 1 | 1990 | 7 | 0.020 |
Why?
|
| Citrobacter | 2 | 2000 | 21 | 0.020 |
Why?
|
| Calcitriol | 1 | 2010 | 82 | 0.020 |
Why?
|
| Cytosol | 2 | 2000 | 161 | 0.020 |
Why?
|
| Deoxycholic Acid | 1 | 1989 | 13 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1994 | 1085 | 0.020 |
Why?
|
| Inflammation | 1 | 2016 | 1411 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1989 | 135 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1990 | 273 | 0.020 |
Why?
|
| Electrolytes | 1 | 1989 | 51 | 0.020 |
Why?
|
| Pelvic Neoplasms | 1 | 1989 | 21 | 0.020 |
Why?
|
| Diverticulum, Colon | 1 | 1988 | 4 | 0.020 |
Why?
|
| Sulfhydryl Reagents | 1 | 1988 | 7 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1990 | 469 | 0.020 |
Why?
|
| Arteriovenous Malformations | 1 | 1988 | 47 | 0.020 |
Why?
|
| Gluconates | 1 | 1987 | 6 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 578 | 0.020 |
Why?
|
| Choline | 1 | 1987 | 54 | 0.020 |
Why?
|
| Emergencies | 1 | 1988 | 173 | 0.020 |
Why?
|
| Colforsin | 2 | 2000 | 48 | 0.020 |
Why?
|
| Hospitalization | 1 | 2014 | 1753 | 0.020 |
Why?
|
| Endometriosis | 1 | 1989 | 177 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 1991 | 540 | 0.020 |
Why?
|
| Calcifediol | 1 | 1984 | 13 | 0.010 |
Why?
|
| Calcimycin | 1 | 1984 | 26 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1991 | 998 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1984 | 72 | 0.010 |
Why?
|
| Albumins | 1 | 1984 | 89 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 1984 | 119 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1999 | 14076 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2001 | 6084 | 0.010 |
Why?
|
| Amylases | 1 | 2001 | 26 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2001 | 75 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 1 | 2001 | 12 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2001 | 101 | 0.010 |
Why?
|
| Microvilli | 1 | 2001 | 72 | 0.010 |
Why?
|
| Butyrates | 1 | 2001 | 35 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 1980 | 32 | 0.010 |
Why?
|
| Rats | 2 | 2001 | 3687 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2000 | 157 | 0.010 |
Why?
|
| United States | 1 | 2014 | 10767 | 0.010 |
Why?
|
| Indoles | 1 | 2000 | 182 | 0.010 |
Why?
|
| Antibodies | 1 | 2000 | 371 | 0.010 |
Why?
|
| Pyrroles | 1 | 2000 | 179 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2000 | 488 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 665 | 0.010 |
Why?
|
| Hepatocyte Growth Factor | 1 | 1996 | 28 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1996 | 42 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1996 | 105 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1996 | 204 | 0.010 |
Why?
|
| Dogs | 1 | 1996 | 767 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 3050 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 3873 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2000 | 1701 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2000 | 2824 | 0.010 |
Why?
|
| Wound Healing | 1 | 1996 | 456 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1996 | 1400 | 0.010 |
Why?
|
| Gallic Acid | 1 | 1991 | 3 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1991 | 90 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 1991 | 113 | 0.010 |
Why?
|
| Cell Line | 1 | 1996 | 2770 | 0.010 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 1990 | 3 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1991 | 606 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2000 | 4532 | 0.000 |
Why?
|
| Calcium Radioisotopes | 1 | 1984 | 2 | 0.000 |
Why?
|
| Calcium Chloride | 1 | 1984 | 22 | 0.000 |
Why?
|
| Polymers | 1 | 1984 | 108 | 0.000 |
Why?
|
| Osteomalacia | 1 | 1980 | 7 | 0.000 |
Why?
|
| Vitamin D | 1 | 1980 | 159 | 0.000 |
Why?
|